Clinical safety of robenacoxib in cats with chronic musculoskeletal disease

BACKGROUND: Evaluate the clinical safety of robenacoxib in cats with chronic musculoskeletal disease (CMSD). ANIMALS: Four hundred forty‐nine client‐owned cats with CMSD. METHODS: Pooled analysis of safety variables from 4 prospective randomized blinded clinical trials of robenacoxib (n = 222) versu...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jonathan N., Seewald, Wolfgang, Forster, Sophie, Friton, Gabriele, Adrian, Derek E., Lascelles, B. Duncan X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478032/
https://www.ncbi.nlm.nih.gov/pubmed/34196973
http://dx.doi.org/10.1111/jvim.16148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478032/
https://www.ncbi.nlm.nih.gov/pubmed/34196973
http://dx.doi.org/10.1111/jvim.16148

Ejemplares similares